Advertisement
UK markets close in 3 hours 5 minutes

  • FTSE 100

    8,115.53
    +36.67 (+0.45%)
     

  • FTSE 250

    19,802.13
    +200.15 (+1.02%)
     

  • AIM

    754.71
    +1.59 (+0.21%)
     

  • GBP/EUR

    1.1668
    +0.0012 (+0.10%)
     

  • GBP/USD

    1.2508
    -0.0003 (-0.02%)
     

  • Bitcoin GBP

    51,434.73
    +266.82 (+0.52%)
     

  • CMC Crypto 200

    1,387.65
    -8.88 (-0.64%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.44
    +0.87 (+1.04%)
     

  • GOLD FUTURES

    2,355.40
    +12.90 (+0.55%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,047.16
    +129.88 (+0.72%)
     

  • CAC 40

    8,042.44
    +25.79 (+0.32%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BUZZ-NPS Pharma Inc: Shire considering bid - Bloomberg

Reuters - UK Focus

** Shire Plc (Xetra: S7E.DE - news) considering bid for NPS Pharmaceuticals Inc, Bloomberg reports (http://bloom.bg/1wFFJ3T)

** U.S. biopharma company NPS's shares up 21.3 pct at $36.95 in heavy trading

** Ireland (Other OTC: IRLD - news) -based Shire's shares up 1.9 pct at $212.64

** Timing of a possible bid depends on whether U.S. FDA approves NPS's hormone replacement therapy, Natpara, Bloomberg reports

** NPS's stock spikes to a six-month high of $37.50 after the report, joins rank of top percentage gainers on the Nasdaq

** More than 3 mln NPS shares traded, double its 50-day average

** Shire and NPS not immediately available for comment